← Back to Search

Procedure

Deep Brain Stimulation for Treatment-Resistant Depression

N/A
Recruiting
Research Sponsored by Helen Mayberg, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and up to 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial uses a device to send electrical signals to a specific brain area in patients with severe depression that hasn't improved with other treatments. The goal is to see if this can help reduce their symptoms by resetting brain activity. The study will monitor changes in brain signals and patient symptoms.

Who is the study for?
This trial is for adults aged 25-70 living in the New York area with Major Depressive Disorder (MDD) that hasn't improved after trying at least four different treatments. They should be experiencing a severe depressive episode lasting two years or have had more than three episodes. Participants must be able to follow study procedures and give written consent.
What is being tested?
The trial tests Deep Brain Stimulation (DBS) using the Medtronic Percept PC system on patients with treatment-resistant depression. It involves placing electrodes in the brain and stimulating it to potentially alleviate symptoms. The study also aims to identify biomarkers related to DBS effectiveness.
What are the potential side effects?
Potential side effects may include discomfort from surgery, risk of infection, headache, confusion, speech problems, and changes in mood or behavior due to brain stimulation. Side effects can vary based on individual responses.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and up to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and up to 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Hamilton Depression Rating Scale (HDRS) score
Secondary study objectives
Change in Montgomery-Asberg Depression Rating Scale (MADRS)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Deep Brain Stimulation (DBS) for Treatment Resistant DepressionExperimental Treatment1 Intervention
Open label active Deep Brain Stimulation (DBS)

Find a Location

Who is running the clinical trial?

Helen Mayberg, MDLead Sponsor
1 Previous Clinical Trials
10 Total Patients Enrolled

Media Library

Medtronic Percept PC DBS system (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05773755 — N/A
Major Depressive Disorder Research Study Groups: Deep Brain Stimulation (DBS) for Treatment Resistant Depression
Major Depressive Disorder Clinical Trial 2023: Medtronic Percept PC DBS system Highlights & Side Effects. Trial Name: NCT05773755 — N/A
Medtronic Percept PC DBS system (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05773755 — N/A
~7 spots leftby Dec 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top